Dr. Deepika Polineni is an Assistant Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine at the University of Kansas Health System, and Associate Adult Program Director for the University of Kansas CF Care Center. She received her Bachelor of Arts and Doctor of Medicine degrees from the University of Missouri, Kansas City, and Master of Public Health degree from Boston University. She completed internship and residency in Internal Medicine at the University of Michigan Ann Arbor, fellowship in Pulmonary Medicine at the University of North Carolina at Chapel Hill, and post-doctoral research in pulmonary medicine at Washington University in St. Louis. Dr. Polineni's research interests include the identification of non-CFTR genetic modifiers of cystic fibrosis (CF) lung disease, as well as developing methods for improving treatment adherence in CF. Her long-standing research focus has been in-vivo transcriptomic and metabolomic studies to identify differential gene expression and metabolite variability associated with CF lung disease severity. These studies are complementary to ongoing genomic studies of the International CF Modifiers Consortium, with the goal of advancing personalized CF therapies. She has additionally begun a multi-center clinical trial, through the CFF Success with Therapies Research Consortium, to study novel tele-communication based methods aimed at improving treatment adherence in complex CF care regimens.